Healthcare - Biotechnology - NASDAQ - US
$ 0.295
-1.57 %
$ 9.9 M
Market Cap
-0.28
P/E
BALANCE SHEET
18.2 M
ASSETS
7 M
LIABILITIES
11.2 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Vincerx Pharma, Inc.
| Current Assets | 14.7 M |
| Cash & Short-Term Investments | 12.8 M |
| Receivables | 0 |
| Other Current Assets | 1.95 M |
| Non-Current Assets | 3.48 M |
| Long-Term Investments | 0 |
| PP&E | 2.33 M |
| Other Non-Current Assets | 1.16 M |
| Current Liabilities | 5.6 M |
| Accounts Payable | 2.5 M |
| Short-Term Debt | 2.32 M |
| Other Current Liabilities | 784 K |
| Non-Current Liabilities | 1.39 M |
| Long-Term Debt | 1.34 M |
| Other Non-Current Liabilities | 50 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 12.8 | 11.7 | 111.5 | 61.8 | 0.7 |
| Short Term Investments | 0 | 40.8 | 0 | 0 | 0 |
| Receivables | 0 | 1.4 | 0 | 0 | 0 |
| Inventory | 0 | (1.2) | 0 | 0 | 0 |
| Other Current Assets | 2.0 | 2.1 | 0.4 | 1.3 | 0.1 |
| Total Current Assets | 14.7 | 56.0 | 111.8 | 63.1 | 0.8 |
| PP&E | 2.3 | 3.2 | 4.2 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 65.7 | 1 K |
| Other Long Term Assets | 1.2 | 81 K | 1.7 | (65.6) | 0 |
| Other Assets | 0 | 0 | 0 | 0 | (0.8) |
| Total Assets | 18.2 | 59.3 | 117.7 | 63.2 | 1 K |
| LIABILITIES | |||||
| Accounts Payable | 2.5 | 4.1 | 2.0 | 0.5 | 35 K |
| Short Term Debt | 2.3 | 2.0 | 1.5 | 0 | 0 |
| Other Current Liabilities | 0.8 | 3.0 | 10.4 | 37.3 | 8.19 K |
| Total Current Liabilities | 5.6 | 9.2 | 13.9 | 5.5 | 44 K |
| Long Term Debt | 1.3 | 2.4 | 3.4 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 50 K | 50 K | 0 | 0 | 0 |
| Total Liabilities | 7.0 | 11.6 | 17.4 | 5.5 | 44 K |
| EQUITY | |||||
| Common Stock | 2 K | 2 K | 2 K | 1 K | 1 K |
| Retained Earnings | (159.1) | (121.3) | (56.0) | (10.8) | 45 K |
| Other Accumulative Comprehensive Income/Loss | 8 K | 26 K | 21 K | 0 | 1 |
| Total Equity | 11.2 | 47.7 | 100.3 | 57.7 | 44 K |
| Total Liabilities and Equity | 18.2 | 59.3 | 117.7 | 63.2 | 1 K |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 21.3 | 21.0 | 17.2 | 14.0 | 5.2 |